Mitchell B. Beattie

Vancouver, BC V6T1Z3, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination.

Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2026

Enhancing Osseointegration With LNP-Delivered mRNA-Encoded BMP-2: An Experimental In Vivo Study.

Enhancing Osseointegration With LNP-Delivered mRNA-Encoded BMP-2: An Experimental In Vivo Study.

Journal: Clinical oral implants research
Published: March 31, 2025

A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection.

A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection.

Journal: Science (New York, N.Y.)
Published: October 03, 2024

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.

Journal: Viruses
Published: June 10, 2023

A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets.

A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets.

Journal: Science advances
Published: December 14, 2022

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 02, 2022

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury.

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury.

Journal: Research (Washington, D.C.)
Published: August 24, 2022

Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines.

Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines.

Journal: Molecular therapy. Nucleic acids
Published: February 14, 2022

Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.

Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.

Journal: Journal of virology
Published: November 24, 2021

Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA.

Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA.

Journal: Nature communications
Published: May 11, 2021

Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNA.

Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNA.

Journal: Bio-protocol
Published: April 28, 2021

Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice.

Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice.

Journal: Molecular therapy. Methods & clinical development
Published: November 04, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026